ReP USP - Resultado da busca

Filtros : "GRU999FBF" "FCF" Removidos: "Oliveira, Maricê Nogueira de" "SOUZA, DANIELA CARLA DE" "Colômbia" Limpar

Filtros

USP affiliated authors
- ferreira, elizabeth igne alves (1)
- kupa, leonard de vinci kanda (1)
- pinto, débora cristina sanches (1)
- santos, silvia regina cavani jorge (1)
- silva junior, joão manoel da (1)

Date published
- 2024 (~1)
- 2023 (~1)
Subjects
- choque séptico (1)
- desenvolvimento de produtos (1)
- doença de chagas (1)
- fármacos (1)
- produtos novos (1)

Artigo de periodico
Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi (2024)
Prates, João Lucas Bruno; Lopes, Juliana Romano ; Chin, Chung Man ; Ferreira, Elizabeth Igne ; Santos, Jean Leandro dos ; Scarim, Cauê Benito
Source: Current Medicinal Chemistry. Unidade: FCF
Subjects: TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS, DESENVOLVIMENTO DE PRODUTOS, PRODUTOS NOVOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRATES, João Lucas Bruno et al. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, v. 31, n. 16, p. 2285-2308, 2024Tradução . . Disponível em: https://dx.doi.org/10.2174/0109298673254864230921090. Acesso em: 29 maio 2024.
APA
Prates, J. L. B., Lopes, J. R., Chin, C. M., Ferreira, E. I., Santos, J. L. dos, & Scarim, C. B. (2024). Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, 31( 16), 2285-2308. doi:10.2174/0109298673254864230921090
NLM
Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 maio 29 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
Vancouver
Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 maio 29 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
Artigo de periodico
Combined vancomycin-meropenem therapy in pediatric major burns undergoing therapy of septic shock guided by cultures and pharmacokinetic-pharmacodynamics approach based on serum levels to combat bacterial resistance (2023)
Santos, Silvia Regina Cavani Jorge ; Camargo, Thais Vieira de ; Messiano, Claudia Garcia ; Kupa, Leonard de Vinci Kanda ; Morales Júnior, Ronaldo ; Souza, Vanessa Kazubeck de; Pires, Frederico Ribeiro; Pinto, Débora Cristina Sanches ; Campos, Edvaldo Vieira de ; Silva Junior, Elson Mendes da ; Silva Junior, João Manoel da
Source: Pharmacy and Pharmacology International Journal. Unidades: FCF, FM
Subjects: CHOQUE SÉPTICO, QUEIMADURAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Silvia Regina Cavani Jorge et al. Combined vancomycin-meropenem therapy in pediatric major burns undergoing therapy of septic shock guided by cultures and pharmacokinetic-pharmacodynamics approach based on serum levels to combat bacterial resistance. Pharmacy and Pharmacology International Journal, v. 11, n. 2, p. 62‒68, 2023Tradução . . Disponível em: https://dx.doi.org/10.15406/ppij.2023.11.00403. Acesso em: 29 maio 2024.
APA
Santos, S. R. C. J., Camargo, T. V. de, Messiano, C. G., Kupa, L. de V. K., Morales Júnior, R., Souza, V. K. de, et al. (2023). Combined vancomycin-meropenem therapy in pediatric major burns undergoing therapy of septic shock guided by cultures and pharmacokinetic-pharmacodynamics approach based on serum levels to combat bacterial resistance. Pharmacy and Pharmacology International Journal, 11( 2), 62‒68. doi:10.15406/ppij.2023.11.00403
NLM
Santos SRCJ, Camargo TV de, Messiano CG, Kupa L de VK, Morales Júnior R, Souza VK de, Pires FR, Pinto DCS, Campos EV de, Silva Junior EM da, Silva Junior JM da. Combined vancomycin-meropenem therapy in pediatric major burns undergoing therapy of septic shock guided by cultures and pharmacokinetic-pharmacodynamics approach based on serum levels to combat bacterial resistance [Internet]. Pharmacy and Pharmacology International Journal. 2023 ; 11( 2): 62‒68.[citado 2024 maio 29 ] Available from: https://dx.doi.org/10.15406/ppij.2023.11.00403
Vancouver
Santos SRCJ, Camargo TV de, Messiano CG, Kupa L de VK, Morales Júnior R, Souza VK de, Pires FR, Pinto DCS, Campos EV de, Silva Junior EM da, Silva Junior JM da. Combined vancomycin-meropenem therapy in pediatric major burns undergoing therapy of septic shock guided by cultures and pharmacokinetic-pharmacodynamics approach based on serum levels to combat bacterial resistance [Internet]. Pharmacy and Pharmacology International Journal. 2023 ; 11( 2): 62‒68.[citado 2024 maio 29 ] Available from: https://dx.doi.org/10.15406/ppij.2023.11.00403

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024